×
About 552 results

ALLMedicine™ Breast Cancer Chemotherapy Center

Research & Reviews  247 results

A deep-learning semantic segmentation approach to fully automated MRI-based left-ventri...
https://doi.org/10.1016/j.mri.2021.01.005
Magnetic Resonance Imaging; Kar BJ, Cohen MV et. al.

Feb 11th, 2021 - Left-ventricular (LV) strain measurements with the Displacement Encoding with Stimulated Echoes (DENSE) MRI sequence provide accurate estimates of cardiotoxicity damage related to breast cancer chemotherapy. This study investigated an automated LV...

Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal ...
https://doi.org/10.1080/17425247.2020.1813714
Expert Opinion on Drug Delivery; Haggag Y, Abu Ras B et. al.

Aug 25th, 2020 - Multidrug resistance (MDR) limits the beneficial outcomes of conventional breast cancer chemotherapy. Ras-related nuclear protein (Ran-GTP) plays a key role in these resistance mechanisms, assisting cancer cells to repair damage to DNA. Herein, we...

Risk of secondary hematologic malignancies associated with breast cancer chemotherapy a...
https://doi.org/10.1002/ijc.33216
International Journal of Cancer REFERENCES; Jabagi MJ, Vey N et. al.

Jul 19th, 2020 - Our study aimed to analyze the risk of hematologic malignancies (HM) associated with the use of G-CSF with chemotherapy for BC. Using the French National Health Data System, we examined the HM risks in patients diagnosed with an incident breast ca...

see more →

Guidelines  5 results

Gene-Expression Profiling Raises Costs for Cancer Care without Improving Outcomes for Low-Risk Breast Cancer Patients, According to Researchers
https://www.nccn.org/about/news/newsinfo.aspx?NewsID=1382

Jan 22nd, 2019 - New research in the January 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network reports that using Oncotype DX (ODX)—the most commonly used test for predicting the benefit of adjuvant chemotherapy to reduce the risk of disease...

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
http://ascopubs.org/doi/full/10.1200/JCO.2018.78.8604
Neelima Denduluri

Oct 9th, 2018 - To update key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer.

ACR Appropriateness Criteria ® Monitoring Response to Neoadjuvant Systemic Therapy for Breas...
https://linkinghub.elsevier.com/retrieve/pii/S154614401731092X
Slanetz, P.

Oct 31st, 2017 - Patients with locally advanced invasive breast cancers are often treated with neoadjuvant chemotherapy prior to definitive surgical intervention. The primary aims of this approach are to: 1) reduce tumor burden thereby permitting breast conservati.

Chemo- and Targeted Therapy for Women with HER2 Negative (or unknown) Advanced Breast Cancer
http://ascopubs.org/doi/full/10.1200/jco.2014.56.7479
Ann H. Partridge

Oct 9th, 2014 - To identify optimal chemo- and targeted therapy for women with HER2 negative (or unknown) advanced breast cancer.

Use of Chemotherapy and Radiation Therapy Protectants Update
http://ascopubs.org/doi/full/10.1200/jco.2008.17.2627
Martee L. Hensley

Dec 31st, 2008 - Dexrazoxane: not recommended for routine use in breast cancer (BC) in adjuvant setting, or metastatic setting with initial doxorubicin-based chemotherapy. Consider use with metastatic BC and other malignancies, for patients who have received >300.

see more →

Clinicaltrials.gov  281 results

A deep-learning semantic segmentation approach to fully automated MRI-based left-ventri...
https://doi.org/10.1016/j.mri.2021.01.005
Magnetic Resonance Imaging; Kar BJ, Cohen MV et. al.

Feb 11th, 2021 - Left-ventricular (LV) strain measurements with the Displacement Encoding with Stimulated Echoes (DENSE) MRI sequence provide accurate estimates of cardiotoxicity damage related to breast cancer chemotherapy. This study investigated an automated LV...

Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal ...
https://doi.org/10.1080/17425247.2020.1813714
Expert Opinion on Drug Delivery; Haggag Y, Abu Ras B et. al.

Aug 25th, 2020 - Multidrug resistance (MDR) limits the beneficial outcomes of conventional breast cancer chemotherapy. Ras-related nuclear protein (Ran-GTP) plays a key role in these resistance mechanisms, assisting cancer cells to repair damage to DNA. Herein, we...

Risk of secondary hematologic malignancies associated with breast cancer chemotherapy a...
https://doi.org/10.1002/ijc.33216
International Journal of Cancer REFERENCES; Jabagi MJ, Vey N et. al.

Jul 19th, 2020 - Our study aimed to analyze the risk of hematologic malignancies (HM) associated with the use of G-CSF with chemotherapy for BC. Using the French National Health Data System, we examined the HM risks in patients diagnosed with an incident breast ca...

see more →

News  19 results

Gene-Expression Profiling Raises Costs for Cancer Care without Improving Outcomes for Low-Risk Breast Cancer Patients, According to Researchers
https://www.nccn.org/about/news/newsinfo.aspx?NewsID=1382

Jan 22nd, 2019 - New research in the January 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network reports that using Oncotype DX (ODX)—the most commonly used test for predicting the benefit of adjuvant chemotherapy to reduce the risk of disease...

Ovarian suppression during breast cancer chemotherapy helped preserve long-term function
https://www.mdedge.com/internalmedicine/article/105361/breast-cancer/ovarian-suppression-during-breast-cancer-chemotherapy
Amy Karon

Dec 22nd, 2015 - Ovarian suppression with triptorelin during chemotherapy for early-stage breast cancer significantly increased the chances that women would recover their long-term ovarian function, according to a multicenter phase III open-label study published o.

Breast Cancer Patients Fare Worse When Adjuvant Chemotherapy Is Delayed
https://www.onclive.com/publications/obtn/2014/march-2014/breast-cancer-patients-fare-worse-when-adjuvant-chemotherapy-is-delayed

Apr 3rd, 2014 - Mariana Chavez-MacGregor, MD Breast cancer patients whose chemotherapy is initiated >60 days following surgery experience worse survival outcomes, according to a large, retrospective review of patient medical records conducted by Mariana Chavez-Ma...

Strong Case for Weekly Paclitaxel in Breast Cancer
https://www.medscape.com/viewarticle/805220

Jun 2nd, 2013 - CHICAGO, Illinois — In a result that should change clinical practice, a low-dose weekly schedule of the breast cancer chemotherapy stalwart paclitaxel appears to be less toxic than the standard "dose-dense" biweekly administration of the drug, acc...

see more →